Consensus $50M. The Company expects operating expenses of less than $40.0 million for the year ended December 31, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APYX:
- Is APYX a Buy, Before Earnings?
- Hold Rating for Apyx Medical Amid Promising Ayon System and Challenging Market Conditions
- Apyx Medical submits FDA 510k to U.S. FDA for label expansion of AYON
- Needham medtech & diagnostics analysts hold analyst/industry conference call
- Apyx Medical’s Renuvion APR System: Promising Results in Facelift Surgery Study